Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer by providing new options in addition to existing therapies. However, peptide vaccination therapies still represent an attractive approach, because of the antigen specificity. We identified survivin 2B peptide (SVN‐2B), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Terufumi, Tsurita, Giichiro, Hirohashi, Yoshihiko, Yasui, Hiroshi, Ota, Yasunori, Watanabe, Kazue, Murai, Aiko, Matsuo, Kazuhiko, Asanuma, Hiroko, Shima, Hiroaki, Wada, Satoshi, Nakatsugawa, Munehide, Kanaseki, Takayuki, Tsukahara, Tomohide, Mizuguchi, Toru, Hirata, Koichi, Takemasa, Ichiro, Imai, Kohzoh, Sato, Noriyuki, Torigoe, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676134/
https://www.ncbi.nlm.nih.gov/pubmed/31206934
http://dx.doi.org/10.1111/cas.14099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676134/
https://www.ncbi.nlm.nih.gov/pubmed/31206934
http://dx.doi.org/10.1111/cas.14099

Ejemplares similares